Skip to main content
Erschienen in: Journal of Nuclear Cardiology 5/2012

01.10.2012 | Review Article

Non-invasive quantification of coronary vascular dysfunction for diagnosis and management of coronary artery disease

verfasst von: Venkatesh L. Murthy, MD, PhD, Marcelo F. Di Carli, MD

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Excerpt

The last several decades have seen significant advances in the evaluation and treatment of coronary artery disease. Multiple non-invasive methods for the diagnosis of coronary atherosclerosis have matured and are in wide clinical practice. Improving risk factors and primary1,2 and secondary prevention strategies3 have resulted in a decline in cardiac mortality and myocardial infarction.4,5 The focus of these diagnostic methods and treatment strategies has been on the identification and treatment of atherosclerotic lesions of the epicardial coronary arteries, particularly obstructive, ischemia causing lesions. While there is no doubt that this approach has been tremendously successful, it must be noted the coronary arterial circulation extends from large epicardial conduit arteries through resistance arterioles (i.e., the microvasculature) to the intra-myocardial capillary bed. Dysfunction of the microvasculature and pre-obstructive disease of the epicardial arteries can not only cause typical anginal symptoms but also may be harbingers of adverse prognosis. In the following paragraphs, we will discuss current approaches to the quantification of coronary vascular function and the evidence supporting its potential diagnostic and prognostic implications with a particular focus on ischemic heart disease. …
Literatur
1.
Zurück zum Zitat Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
2.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52.PubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52.PubMed
3.
Zurück zum Zitat Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. Circulation 2011;124:2458-73.PubMed Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. Circulation 2011;124:2458-73.PubMed
4.
Zurück zum Zitat Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2012 update: A report from the American Heart Association. Circulation 2012;125:e2-220.PubMed Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2012 update: A report from the American Heart Association. Circulation 2012;125:e2-220.PubMed
5.
Zurück zum Zitat Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98.PubMed Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98.PubMed
6.
Zurück zum Zitat Gibbons RJ, Balady GJ, Timothy Bricker J, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1997 exercise testing guidelines). Circulation 2002;106:1883-92.PubMed Gibbons RJ, Balady GJ, Timothy Bricker J, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1997 exercise testing guidelines). Circulation 2002;106:1883-92.PubMed
7.
Zurück zum Zitat Jaarsma C, Leiner T, Bekkers SC, Crijns HJ, Wildberger JE, Nagel E, et al. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: A meta-analysis. J Am Coll Cardiol 2012;59:1719-28.PubMed Jaarsma C, Leiner T, Bekkers SC, Crijns HJ, Wildberger JE, Nagel E, et al. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: A meta-analysis. J Am Coll Cardiol 2012;59:1719-28.PubMed
8.
Zurück zum Zitat Cerqueira MD, Allman KC, Ficaro EP, Hansen CL, Nichols KJ, Thompson RC, et al. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol 2010;17:709-18.PubMed Cerqueira MD, Allman KC, Ficaro EP, Hansen CL, Nichols KJ, Thompson RC, et al. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol 2010;17:709-18.PubMed
9.
Zurück zum Zitat Salerno M, Beller GA. Noninvasive assessment of myocardial perfusion. Circ Cardiovasc Imaging 2009;2:412-24.PubMed Salerno M, Beller GA. Noninvasive assessment of myocardial perfusion. Circ Cardiovasc Imaging 2009;2:412-24.PubMed
10.
Zurück zum Zitat Nygaard TW, Gibson RS, Ryan JM, Gascho JA, Watson DD, Beller GA. Prevalence of high-risk thallium-201 scintigraphic findings in left main coronary artery stenosis: Comparison with patients with multiple- and single-vessel coronary artery disease. Am J Cardiol 1984;53:462-9.PubMed Nygaard TW, Gibson RS, Ryan JM, Gascho JA, Watson DD, Beller GA. Prevalence of high-risk thallium-201 scintigraphic findings in left main coronary artery stenosis: Comparison with patients with multiple- and single-vessel coronary artery disease. Am J Cardiol 1984;53:462-9.PubMed
11.
Zurück zum Zitat Weiss AT, Berman DS, Lew AS, Nielsen J, Potkin B, Swan HJ, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: A marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752-9.PubMed Weiss AT, Berman DS, Lew AS, Nielsen J, Potkin B, Swan HJ, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: A marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752-9.PubMed
12.
Zurück zum Zitat McLaughlin MG, Danias PG. Transient ischemic dilation: A powerful diagnostic and prognostic finding of stress myocardial perfusion imaging. J Nucl Cardiol 2002;9:663-7.PubMed McLaughlin MG, Danias PG. Transient ischemic dilation: A powerful diagnostic and prognostic finding of stress myocardial perfusion imaging. J Nucl Cardiol 2002;9:663-7.PubMed
13.
Zurück zum Zitat Abidov A, Bax JJ, Hayes SW, Cohen I, Nishina H, Yoda S, et al. Integration of automatically measured transient ischemic dilation ratio into interpretation of adenosine stress myocardial perfusion SPECT for detection of severe and extensive CAD. J Nucl Med 2004;45:1999-2007.PubMed Abidov A, Bax JJ, Hayes SW, Cohen I, Nishina H, Yoda S, et al. Integration of automatically measured transient ischemic dilation ratio into interpretation of adenosine stress myocardial perfusion SPECT for detection of severe and extensive CAD. J Nucl Med 2004;45:1999-2007.PubMed
14.
Zurück zum Zitat Boucher CA, Zir LM, Beller GA, Okada RD, McKusick KA, Strauss HW, et al. Increased lung uptake of thallium-201 during exercise myocardial imaging: Clinical, hemodynamic and angiographic implications in patients with coronary artery disease. Am J Cardiol 1980;46:189-96.PubMed Boucher CA, Zir LM, Beller GA, Okada RD, McKusick KA, Strauss HW, et al. Increased lung uptake of thallium-201 during exercise myocardial imaging: Clinical, hemodynamic and angiographic implications in patients with coronary artery disease. Am J Cardiol 1980;46:189-96.PubMed
15.
Zurück zum Zitat Kushner FG, Okada RD, Kirshenbaum HD, Boucher CA, Strauss HW, Pohost GM. Lung thallium-201 uptake after stress testing in patients with coronary artery disease. Circulation 1981;63:341-7.PubMed Kushner FG, Okada RD, Kirshenbaum HD, Boucher CA, Strauss HW, Pohost GM. Lung thallium-201 uptake after stress testing in patients with coronary artery disease. Circulation 1981;63:341-7.PubMed
16.
Zurück zum Zitat Gibson RS, Watson DD, Carabello BA, Holt ND, Beller GA. Clinical implications of increased lung uptake of thallium-201 during exercise scintigraphy 2 weeks after myocardial infarction. Am J Cardiol 1982;49:1586-93.PubMed Gibson RS, Watson DD, Carabello BA, Holt ND, Beller GA. Clinical implications of increased lung uptake of thallium-201 during exercise scintigraphy 2 weeks after myocardial infarction. Am J Cardiol 1982;49:1586-93.PubMed
17.
Zurück zum Zitat Levy R, Rozanski A, Berman DS, Garcia E, Van Train K, Maddahi J, et al. Analysis of the degree of pulmonary thallium washout after exercise in patients with coronary artery disease. J Am Coll Cardiol 1983;2:719-28.PubMed Levy R, Rozanski A, Berman DS, Garcia E, Van Train K, Maddahi J, et al. Analysis of the degree of pulmonary thallium washout after exercise in patients with coronary artery disease. J Am Coll Cardiol 1983;2:719-28.PubMed
18.
Zurück zum Zitat Williams KA, Schneider CM. Increased stress right ventricular activity on dual isotope perfusion SPECT: A sign of multivessel and/or left main coronary artery disease. J Am Coll Cardiol 1999;34:420-7.PubMed Williams KA, Schneider CM. Increased stress right ventricular activity on dual isotope perfusion SPECT: A sign of multivessel and/or left main coronary artery disease. J Am Coll Cardiol 1999;34:420-7.PubMed
19.
Zurück zum Zitat Johnson LL, Verdesca SA, Aude WY, Xavier RC, Nott LT, Campanella MW, et al. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol 1997;30:1641-8.PubMed Johnson LL, Verdesca SA, Aude WY, Xavier RC, Nott LT, Campanella MW, et al. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol 1997;30:1641-8.PubMed
20.
Zurück zum Zitat Dorbala S, Vangala D, Sampson U, Limaye A, Kwong R, Di Carli MF. Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: A 82Rb PET/CT study. J Nucl Med 2007;48:349-58.PubMed Dorbala S, Vangala D, Sampson U, Limaye A, Kwong R, Di Carli MF. Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: A 82Rb PET/CT study. J Nucl Med 2007;48:349-58.PubMed
21.
Zurück zum Zitat Berman DS, Kang X, Slomka PJ, Gerlach J, de Yang L, Hayes SW, et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol 2007;14:521-8.PubMed Berman DS, Kang X, Slomka PJ, Gerlach J, de Yang L, Hayes SW, et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol 2007;14:521-8.PubMed
22.
Zurück zum Zitat Geleijnse ML, Krenning BJ, van Dalen BM, Nemes A, Soliman OII, Bosch JG, et al. Factors affecting sensitivity and specificity of diagnostic testing: Dobutamine stress echocardiography. J Am Soc Echocardiogr 2009;22:1199-208.PubMed Geleijnse ML, Krenning BJ, van Dalen BM, Nemes A, Soliman OII, Bosch JG, et al. Factors affecting sensitivity and specificity of diagnostic testing: Dobutamine stress echocardiography. J Am Soc Echocardiogr 2009;22:1199-208.PubMed
23.
Zurück zum Zitat Attenhofer CH, Pellikka PA, Oh JK, Roger VL, Sohn DW, Seward JB. Comparison of ischemic response during exercise and dobutamine echocardiography in patients with left main coronary artery disease. J Am Coll Cardiol 1996;27:1171-7.PubMed Attenhofer CH, Pellikka PA, Oh JK, Roger VL, Sohn DW, Seward JB. Comparison of ischemic response during exercise and dobutamine echocardiography in patients with left main coronary artery disease. J Am Coll Cardiol 1996;27:1171-7.PubMed
24.
Zurück zum Zitat Olson CE, Porter TR, Deligonul U, Xie F, Anderson JR. Left ventricular volume changes during dobutamine stress echocardiography identify patients with more extensive coronary artery disease. J Am Coll Cardiol 1994;24:1268-73.PubMed Olson CE, Porter TR, Deligonul U, Xie F, Anderson JR. Left ventricular volume changes during dobutamine stress echocardiography identify patients with more extensive coronary artery disease. J Am Coll Cardiol 1994;24:1268-73.PubMed
25.
Zurück zum Zitat Andrade MJ, Picano E, Pingitore A, Petix N, Mazzoni V, Landi P, et al. Dipyridamole stress echocardiography in patients with severe left main coronary artery narrowing. Echo Persantine International Cooperative (EPIC) Study Group—Subproject “Left Main Detection”. Am J Cardiol 1994;73:450-5.PubMed Andrade MJ, Picano E, Pingitore A, Petix N, Mazzoni V, Landi P, et al. Dipyridamole stress echocardiography in patients with severe left main coronary artery narrowing. Echo Persantine International Cooperative (EPIC) Study Group—Subproject “Left Main Detection”. Am J Cardiol 1994;73:450-5.PubMed
26.
Zurück zum Zitat Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): A prospective trial. Lancet 2012;379:453-60.PubMed Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): A prospective trial. Lancet 2012;379:453-60.PubMed
27.
Zurück zum Zitat Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, et al. MR-IMPACT II: Magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: Perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: A comparative multicentre, multivendor trial. Eur Heart J March 4, 2012. http://eurheartj.oxfordjournals.org/content/early/2012/03/04/eurheartj.ehs022. Accessed March 12, 2012. Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, et al. MR-IMPACT II: Magnetic resonance imaging for myocardial perfusion assessment in coronary artery disease trial: Perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: A comparative multicentre, multivendor trial. Eur Heart J March 4, 2012. http://​eurheartj.​oxfordjournals.​org/​content/​early/​2012/​03/​04/​eurheartj.​ehs022. Accessed March 12, 2012.
29.
Zurück zum Zitat Paech DC, Weston AR. A systematic review of the clinical effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of suspected coronary artery disease. BMC Cardiovasc Disord 2011;11:32.PubMed Paech DC, Weston AR. A systematic review of the clinical effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of suspected coronary artery disease. BMC Cardiovasc Disord 2011;11:32.PubMed
30.
Zurück zum Zitat Tamarappoo BK, Gutstein A, Cheng VY, Nakazato R, Gransar H, Dey D, et al. Assessment of the relationship between stenosis severity and distribution of coronary artery stenoses on multislice computed tomographic angiography and myocardial ischemia detected by single photon emission computed tomography. J Nucl Cardiol 2010;17:791-802.PubMed Tamarappoo BK, Gutstein A, Cheng VY, Nakazato R, Gransar H, Dey D, et al. Assessment of the relationship between stenosis severity and distribution of coronary artery stenoses on multislice computed tomographic angiography and myocardial ischemia detected by single photon emission computed tomography. J Nucl Cardiol 2010;17:791-802.PubMed
31.
Zurück zum Zitat Kunadian V, Harrigan C, Zorkun C, Palmer AM, Ogando KJ, Biller LH, et al. Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years. J Thromb Thrombolysis 2009;27:316-28.PubMed Kunadian V, Harrigan C, Zorkun C, Palmer AM, Ogando KJ, Biller LH, et al. Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years. J Thromb Thrombolysis 2009;27:316-28.PubMed
32.
Zurück zum Zitat Porto I, Hamilton-Craig C, Brancati M, Burzotta F, Galiuto L, Crea F. Angiographic assessment of microvascular perfusion-myocardial blush in clinical practice. Am Heart J 2010;160:1015-22.PubMed Porto I, Hamilton-Craig C, Brancati M, Burzotta F, Galiuto L, Crea F. Angiographic assessment of microvascular perfusion-myocardial blush in clinical practice. Am Heart J 2010;160:1015-22.PubMed
33.
Zurück zum Zitat Johnson NP, Kirkeeide RL, Gould KL. Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology? J Am Coll Cardiol Imaging 2012;5:193-202. Johnson NP, Kirkeeide RL, Gould KL. Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology? J Am Coll Cardiol Imaging 2012;5:193-202.
34.
Zurück zum Zitat Lim MJ, Kern MJ. Coronary pathophysiology in the cardiac catheterization laboratory. Curr Probl Cardiol 2006;31:493-550.PubMed Lim MJ, Kern MJ. Coronary pathophysiology in the cardiac catheterization laboratory. Curr Probl Cardiol 2006;31:493-550.PubMed
35.
Zurück zum Zitat El Fakhri G, Sitek A, Guerin B, Kijewski MF, Di Carli MF, Moore SC. Quantitative dynamic cardiac 82Rb PET using generalized factor and compartment analyses. J Nucl Med 2005;46:1264-71.PubMed El Fakhri G, Sitek A, Guerin B, Kijewski MF, Di Carli MF, Moore SC. Quantitative dynamic cardiac 82Rb PET using generalized factor and compartment analyses. J Nucl Med 2005;46:1264-71.PubMed
36.
Zurück zum Zitat Di Carli MF, Dorbala S, Meserve J, El Fakhri G, Sitek A, Moore SC. Clinical myocardial perfusion PET/CT. J Nucl Med 2007;48:783-93.PubMed Di Carli MF, Dorbala S, Meserve J, El Fakhri G, Sitek A, Moore SC. Clinical myocardial perfusion PET/CT. J Nucl Med 2007;48:783-93.PubMed
37.
Zurück zum Zitat Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med 1996;37:1701-12.PubMed Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med 1996;37:1701-12.PubMed
38.
Zurück zum Zitat El Fakhri G, Kardan A, Sitek A, Dorbala S, Abi-Hatem N, Lahoud Y, et al. Reproducibility and accuracy of quantitative myocardial blood flow assessment with 82Rb PET: Comparison with 13N-ammonia PET. J Nucl Med 2009;50:1062-71.PubMed El Fakhri G, Kardan A, Sitek A, Dorbala S, Abi-Hatem N, Lahoud Y, et al. Reproducibility and accuracy of quantitative myocardial blood flow assessment with 82Rb PET: Comparison with 13N-ammonia PET. J Nucl Med 2009;50:1062-71.PubMed
39.
Zurück zum Zitat Yu M, Guaraldi MT, Mistry M, Kagan M, McDonald JL, Drew K, et al. BMS-747158-02: A novel PET myocardial perfusion imaging agent. J Nucl Cardiol 2007;14:789-98.PubMed Yu M, Guaraldi MT, Mistry M, Kagan M, McDonald JL, Drew K, et al. BMS-747158-02: A novel PET myocardial perfusion imaging agent. J Nucl Cardiol 2007;14:789-98.PubMed
40.
Zurück zum Zitat Nekolla SG, Reder S, Saraste A, Higuchi T, Dzewas G, Preissel A, et al. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: Comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation 2009;119:2333-42.PubMed Nekolla SG, Reder S, Saraste A, Higuchi T, Dzewas G, Preissel A, et al. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: Comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation 2009;119:2333-42.PubMed
41.
Zurück zum Zitat Yu M, Bozek J, Guaraldi M, Kagan M, Azure M, Robinson SP. Cardiac imaging and safety evaluation of BMS747158, a novel PET myocardial perfusion imaging agent, in chronic myocardial compromised rabbits. J Nucl Cardiol 2010;17:631-6.PubMed Yu M, Bozek J, Guaraldi M, Kagan M, Azure M, Robinson SP. Cardiac imaging and safety evaluation of BMS747158, a novel PET myocardial perfusion imaging agent, in chronic myocardial compromised rabbits. J Nucl Cardiol 2010;17:631-6.PubMed
42.
Zurück zum Zitat Huisman MC, Higuchi T, Reder S, Nekolla SG, Poethko T, Wester H-J, et al. Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med 2008;49:630-6.PubMed Huisman MC, Higuchi T, Reder S, Nekolla SG, Poethko T, Wester H-J, et al. Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med 2008;49:630-6.PubMed
43.
Zurück zum Zitat Sherif HM, Nekolla SG, Saraste A, Reder S, Yu M, Robinson S, et al. Simplified quantification of myocardial flow reserve with flurpiridaz F 18: Validation with microspheres in a pig model. J Nucl Med 2011;52:617-24.PubMed Sherif HM, Nekolla SG, Saraste A, Reder S, Yu M, Robinson S, et al. Simplified quantification of myocardial flow reserve with flurpiridaz F 18: Validation with microspheres in a pig model. J Nucl Med 2011;52:617-24.PubMed
44.
Zurück zum Zitat Maddahi J, Czernin J, Lazewatsky J, Huang S-C, Dahlbom M, Schelbert H, et al. Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: Dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest. J Nucl Med 2011;52:1490-8.PubMed Maddahi J, Czernin J, Lazewatsky J, Huang S-C, Dahlbom M, Schelbert H, et al. Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: Dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest. J Nucl Med 2011;52:1490-8.PubMed
45.
Zurück zum Zitat Jerosch-Herold M. Quantification of myocardial perfusion by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010;12:57.PubMed Jerosch-Herold M. Quantification of myocardial perfusion by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010;12:57.PubMed
46.
Zurück zum Zitat Jerosch-Herold M, Wilke N, Stillman AE, Wilson RF. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 1998;25:73.PubMed Jerosch-Herold M, Wilke N, Stillman AE, Wilson RF. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 1998;25:73.PubMed
47.
Zurück zum Zitat Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2008;9:415-37.PubMed Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2008;9:415-37.PubMed
48.
Zurück zum Zitat Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473-83.PubMed Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473-83.PubMed
49.
Zurück zum Zitat Christian T, Frankish M, Sisemoore J, Christian M, Gentchos G, Bell S, et al. Myocardial perfusion imaging with first-pass computed tomographic imaging: Measurement of coronary flow reserve in an animal model of regional hyperemia. J Nucl Cardiol 2010;17:625-30.PubMed Christian T, Frankish M, Sisemoore J, Christian M, Gentchos G, Bell S, et al. Myocardial perfusion imaging with first-pass computed tomographic imaging: Measurement of coronary flow reserve in an animal model of regional hyperemia. J Nucl Cardiol 2010;17:625-30.PubMed
50.
Zurück zum Zitat Ho K-T, Chua K-C, Klotz E, Panknin C. Stress and rest dynamic myocardial perfusion imaging by evaluation of complete time-attenuation curves with dual-source CT. JACC Cardiovasc Imaging 2010;3:811-20.PubMed Ho K-T, Chua K-C, Klotz E, Panknin C. Stress and rest dynamic myocardial perfusion imaging by evaluation of complete time-attenuation curves with dual-source CT. JACC Cardiovasc Imaging 2010;3:811-20.PubMed
51.
Zurück zum Zitat Breault C, Roth N, Slomka PJ, Moore SC, Park M, Sitek A, et al. Quantification of myocardial perfusion reserve using dynamic SPECT imaging in humans. Mosby-Year Book Inc: Philadelphia, PA; 2010. Breault C, Roth N, Slomka PJ, Moore SC, Park M, Sitek A, et al. Quantification of myocardial perfusion reserve using dynamic SPECT imaging in humans. Mosby-Year Book Inc: Philadelphia, PA; 2010.
52.
Zurück zum Zitat Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994;330:1782-8.PubMed Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994;330:1782-8.PubMed
53.
Zurück zum Zitat Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang S-C, et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 1995;91:1944-51.PubMed Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang S-C, et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 1995;91:1944-51.PubMed
54.
Zurück zum Zitat Beanlands RSB, Muzik O, Melon P, Sutor R, Sawada S, Muller D, et al. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography: Determination of extent of altered vascular reactivity. J Am Coll Cardiol 1995;26:1465-75.PubMed Beanlands RSB, Muzik O, Melon P, Sutor R, Sawada S, Muller D, et al. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography: Determination of extent of altered vascular reactivity. J Am Coll Cardiol 1995;26:1465-75.PubMed
55.
Zurück zum Zitat Anagnostopoulos C, Almonacid A, Fakhri G, Curillova Z, Sitek A, Roughton M, et al. Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging 2008;35:1593-601.PubMed Anagnostopoulos C, Almonacid A, Fakhri G, Curillova Z, Sitek A, Roughton M, et al. Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging 2008;35:1593-601.PubMed
56.
Zurück zum Zitat Parkash R, de Kemp RA, Ruddy TD, Kitsikis A, Hart R, Beauchesne L, et al. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol 2004;11:440-9.PubMed Parkash R, de Kemp RA, Ruddy TD, Kitsikis A, Hart R, Beauchesne L, et al. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol 2004;11:440-9.PubMed
57.
Zurück zum Zitat Ziadi MC, Dekemp RA, Williams K, Guo A, Renaud JM, Chow BJW, et al. Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol March 14, 2012. http://www.ncbi.nlm.nih.gov/pubmed/22415819, Accessed March 19, 2012. Ziadi MC, Dekemp RA, Williams K, Guo A, Renaud JM, Chow BJW, et al. Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol March 14, 2012. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​22415819, Accessed March 19, 2012.
58.
Zurück zum Zitat Naya M, Murthy VL, Klein J, Foster CR, Gaber M, Oba K, et al. Integrating semiquantitative measures of myocardial ischemia and quantitative coronary flow reserve assessed by 82Rubidium PET for the detection of multivessel coronary artery disease. J Nucl Med 2012;53:1872. Naya M, Murthy VL, Klein J, Foster CR, Gaber M, Oba K, et al. Integrating semiquantitative measures of myocardial ischemia and quantitative coronary flow reserve assessed by 82Rubidium PET for the detection of multivessel coronary artery disease. J Nucl Med 2012;53:1872.
59.
Zurück zum Zitat Fujiwara M, Tamura T, Yoshida K, Nakagawa K, Nakao M, Yamanouchi M, et al. Coronary flow reserve in angiographically normal coronary arteries with one-vessel coronary artery disease without traditional risk factors. Eur Heart J 2001;22:479-87.PubMed Fujiwara M, Tamura T, Yoshida K, Nakagawa K, Nakao M, Yamanouchi M, et al. Coronary flow reserve in angiographically normal coronary arteries with one-vessel coronary artery disease without traditional risk factors. Eur Heart J 2001;22:479-87.PubMed
60.
Zurück zum Zitat De Bruyne B, Hersbach F, Pijls NHJ, Bartunek J, Bech J-W, Heyndrickx GR, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but “normal” coronary angiography. Circulation 2001;104:2401-6.PubMed De Bruyne B, Hersbach F, Pijls NHJ, Bartunek J, Bech J-W, Heyndrickx GR, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but “normal” coronary angiography. Circulation 2001;104:2401-6.PubMed
61.
Zurück zum Zitat Laine H, Raitakari OT, Niinikoski H, Pitkänen O-P, Iida H, Viikari J, et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 1998;32:147-53.PubMed Laine H, Raitakari OT, Niinikoski H, Pitkänen O-P, Iida H, Viikari J, et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 1998;32:147-53.PubMed
62.
Zurück zum Zitat Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994;90:808-17.PubMed Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994;90:808-17.PubMed
63.
Zurück zum Zitat Kaufmann PA, Gnecchi-Ruscone T, Schäfers KP, Lüscher TF, Camici PG. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000;36:103-9.PubMed Kaufmann PA, Gnecchi-Ruscone T, Schäfers KP, Lüscher TF, Camici PG. Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia. J Am Coll Cardiol 2000;36:103-9.PubMed
64.
Zurück zum Zitat Iwado Y, Yoshinaga K, Furuyama H, Ito Y, Noriyasu K, Katoh C, et al. Decreased endothelium-dependent coronary vasomotion in healthy young smokers. Eur J Nucl Med Mol Imaging 2002;29:984-90.PubMed Iwado Y, Yoshinaga K, Furuyama H, Ito Y, Noriyasu K, Katoh C, et al. Decreased endothelium-dependent coronary vasomotion in healthy young smokers. Eur J Nucl Med Mol Imaging 2002;29:984-90.PubMed
65.
Zurück zum Zitat Campisi R, Czernin J, Schoder H, Sayre JW, Marengo FD, Phelps ME, et al. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. Circulation 1998;98:119-25.PubMed Campisi R, Czernin J, Schoder H, Sayre JW, Marengo FD, Phelps ME, et al. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. Circulation 1998;98:119-25.PubMed
66.
Zurück zum Zitat Martin JW, Briesmiester K, Bargardi A, Muzik O, Mosca L, Duvernoy CS. Weight changes and obesity predict impaired resting and endothelium-dependent myocardial blood flow in postmenopausal women. Clin Cardiol 2005;28:13-8.PubMed Martin JW, Briesmiester K, Bargardi A, Muzik O, Mosca L, Duvernoy CS. Weight changes and obesity predict impaired resting and endothelium-dependent myocardial blood flow in postmenopausal women. Clin Cardiol 2005;28:13-8.PubMed
67.
Zurück zum Zitat Motivala AA, Rose PA, Kim HM, Smith YR, Bartnik C, Brook RD, et al. Cardiovascular risk, obesity, and myocardial blood flow in postmenopausal women. J Nucl Cardiol 2008;15:510-7.PubMed Motivala AA, Rose PA, Kim HM, Smith YR, Bartnik C, Brook RD, et al. Cardiovascular risk, obesity, and myocardial blood flow in postmenopausal women. J Nucl Cardiol 2008;15:510-7.PubMed
68.
Zurück zum Zitat Di Carli MF, Charytan D, McMahon GT, Ganz P, Dorbala S, Schelbert HR. Coronary circulatory function in patients with the metabolic syndrome. J Nucl Med 2011;52:1369-77.PubMed Di Carli MF, Charytan D, McMahon GT, Ganz P, Dorbala S, Schelbert HR. Coronary circulatory function in patients with the metabolic syndrome. J Nucl Med 2011;52:1369-77.PubMed
69.
Zurück zum Zitat Di Carli MF, Afonso L, Campisi R, Ramappa P, Bianco-Batlles D, Grunberger G, et al. Coronary vascular dysfunction in premenopausal women with diabetes mellitus. Am Heart J 2002;144:711-8.PubMed Di Carli MF, Afonso L, Campisi R, Ramappa P, Bianco-Batlles D, Grunberger G, et al. Coronary vascular dysfunction in premenopausal women with diabetes mellitus. Am Heart J 2002;144:711-8.PubMed
70.
Zurück zum Zitat Yokoyama I, Momomura S, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y, et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1997;30:1472-7.PubMed Yokoyama I, Momomura S, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y, et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1997;30:1472-7.PubMed
71.
Zurück zum Zitat Di Carli MF, Janisse J, Ager J, Grunberger G. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003;41:1387-93.PubMed Di Carli MF, Janisse J, Ager J, Grunberger G. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003;41:1387-93.PubMed
72.
Zurück zum Zitat Charytan DM, Shelbert HR, Di Carli MF. Coronary microvascular function in early chronic kidney disease/clinical perspective. Circ Cardiovasc Imaging 2010;3:663-71.PubMed Charytan DM, Shelbert HR, Di Carli MF. Coronary microvascular function in early chronic kidney disease/clinical perspective. Circ Cardiovasc Imaging 2010;3:663-71.PubMed
73.
Zurück zum Zitat Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 1995;95:1747-55.PubMed Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 1995;95:1747-55.PubMed
74.
Zurück zum Zitat Cox DA, Vita JA, Treasure CB, Fish RD, Alexander RW, Ganz P, et al. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation 1989;80:458-65.PubMed Cox DA, Vita JA, Treasure CB, Fish RD, Alexander RW, Ganz P, et al. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation 1989;80:458-65.PubMed
75.
Zurück zum Zitat Curillova Z, Yaman BF, Dorbala S, Kwong RY, Sitek A, Fakhri G, et al. Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging. Eur J Nucl Med Mol Imaging 2009;36:1603-10.PubMed Curillova Z, Yaman BF, Dorbala S, Kwong RY, Sitek A, Fakhri G, et al. Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging. Eur J Nucl Med Mol Imaging 2009;36:1603-10.PubMed
76.
Zurück zum Zitat Beltrame JF, Limaye SB, Wuttke RD, Horowitz JD. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J 2003;146:84-90.PubMed Beltrame JF, Limaye SB, Wuttke RD, Horowitz JD. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J 2003;146:84-90.PubMed
77.
Zurück zum Zitat Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim H-W, Scott KN, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 2004;109:2993-9.PubMed Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim H-W, Scott KN, et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 2004;109:2993-9.PubMed
78.
Zurück zum Zitat Suzuki H, Takeyama Y, Koba S, Suwa Y, Katagiri T. Small vessel pathology and coronary hemodynamics in patients with microvascular angina. Int J Cardiol 1994;43:139-50.PubMed Suzuki H, Takeyama Y, Koba S, Suwa Y, Katagiri T. Small vessel pathology and coronary hemodynamics in patients with microvascular angina. Int J Cardiol 1994;43:139-50.PubMed
79.
Zurück zum Zitat Kajander S, Joutsiniemi E, Saraste M, Pietila M, Ukkonen H, Saraste A, et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation 2010;122:603-13.PubMed Kajander S, Joutsiniemi E, Saraste M, Pietila M, Ukkonen H, Saraste A, et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation 2010;122:603-13.PubMed
80.
Zurück zum Zitat Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 2011;124:2215-24.PubMed Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 2011;124:2215-24.PubMed
81.
Zurück zum Zitat Fukushima K, Javadi MS, Higuchi T, Lautamaki R, Merrill J, Nekolla SG, et al. Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging. J Nucl Med 2011;52:726-32.PubMed Fukushima K, Javadi MS, Higuchi T, Lautamaki R, Merrill J, Nekolla SG, et al. Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging. J Nucl Med 2011;52:726-32.PubMed
82.
Zurück zum Zitat Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography: Added value of coronary flow reserve. J Am Coll Cardiol 2009;54:150-6.PubMed Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography: Added value of coronary flow reserve. J Am Coll Cardiol 2009;54:150-6.PubMed
83.
Zurück zum Zitat Tio RA, Dabeshlim A, Siebelink H-MJ, de Sutter J, Hillege HL, Zeebregts CJ, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2009;50:214-9.PubMed Tio RA, Dabeshlim A, Siebelink H-MJ, de Sutter J, Hillege HL, Zeebregts CJ, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2009;50:214-9.PubMed
84.
Zurück zum Zitat Ziadi MC, deKemp RA, Williams KA, Guo A, Chow BJW, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 2011;58:740-8.PubMed Ziadi MC, deKemp RA, Williams KA, Guo A, Chow BJW, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 2011;58:740-8.PubMed
85.
Zurück zum Zitat Zeiher A, Drexler H, Wollschlager H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991;84:1984-92.PubMed Zeiher A, Drexler H, Wollschlager H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991;84:1984-92.PubMed
86.
Zurück zum Zitat Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-906.PubMed Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-906.PubMed
87.
Zurück zum Zitat Halcox JPJ, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002;106:653-8.PubMed Halcox JPJ, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002;106:653-8.PubMed
88.
Zurück zum Zitat Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-54.PubMed Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-54.PubMed
89.
Zurück zum Zitat von Mering GO, Arant CB, Wessel TR, McGorray SP, Bairey Merz CN, Sharaf BL, et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: Results from the national heart, lung, and blood institute-sponsored women’s ischemia syndrome evaluation (WISE). Circulation 2004;109:722-5. von Mering GO, Arant CB, Wessel TR, McGorray SP, Bairey Merz CN, Sharaf BL, et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: Results from the national heart, lung, and blood institute-sponsored women’s ischemia syndrome evaluation (WISE). Circulation 2004;109:722-5.
90.
Zurück zum Zitat Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.PubMed Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.PubMed
91.
Zurück zum Zitat Huggins GS, Pasternak RC, Alpert NM, Fischman AJ, Gewirtz H. Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation 1998;98:1291-6.PubMed Huggins GS, Pasternak RC, Alpert NM, Fischman AJ, Gewirtz H. Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation 1998;98:1291-6.PubMed
92.
Zurück zum Zitat Ishida K, Geshi T, Nakano A, Uzui H, Mitsuke Y, Okazawa H, et al. Beneficial effects of statin treatment on coronary microvascular dysfunction and left ventricular remodeling in patients with acute myocardial infarction. Int J Cardiol 2012;155:442-7.PubMed Ishida K, Geshi T, Nakano A, Uzui H, Mitsuke Y, Okazawa H, et al. Beneficial effects of statin treatment on coronary microvascular dysfunction and left ventricular remodeling in patients with acute myocardial infarction. Int J Cardiol 2012;155:442-7.PubMed
93.
Zurück zum Zitat Alexanderson E, García-Rojas L, Jiménez M, Jácome R, Calleja R, Martínez A, et al. Effect of ezetimibe-simvastatine over endothelial dysfunction in dyslipidemic patients: Assessment by 13N-ammonia positron emission tomography. J Nucl Cardiol 2010;17:1015-22.PubMed Alexanderson E, García-Rojas L, Jiménez M, Jácome R, Calleja R, Martínez A, et al. Effect of ezetimibe-simvastatine over endothelial dysfunction in dyslipidemic patients: Assessment by 13N-ammonia positron emission tomography. J Nucl Cardiol 2010;17:1015-22.PubMed
94.
Zurück zum Zitat Hong SJ, Choi SC, Kim JS, Shim WJ, Park SM, Ahn CM, et al. Low-dose versus moderate-dose atorvastatin after acute myocardial infarction: 8-month effects on coronary flow reserve and angiogenic cell mobilisation. Heart 2010;96:756-64.PubMed Hong SJ, Choi SC, Kim JS, Shim WJ, Park SM, Ahn CM, et al. Low-dose versus moderate-dose atorvastatin after acute myocardial infarction: 8-month effects on coronary flow reserve and angiogenic cell mobilisation. Heart 2010;96:756-64.PubMed
95.
Zurück zum Zitat Baller D, Notohamiprodjo G, Gleichmann U, Holzinger J, Weise R, Lehmann J. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation 1999;99:2871-5.PubMed Baller D, Notohamiprodjo G, Gleichmann U, Holzinger J, Weise R, Lehmann J. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation 1999;99:2871-5.PubMed
96.
Zurück zum Zitat Fujimoto K, Hozumi T, Watanabe H, Shimada K, Takeuchi M, Sakanoue Y, et al. Effect of fluvastatin therapy on coronary flow reserve in patients with hypercholesterolemia. Am J Cardiol 2004;93:1419-21. A10.PubMed Fujimoto K, Hozumi T, Watanabe H, Shimada K, Takeuchi M, Sakanoue Y, et al. Effect of fluvastatin therapy on coronary flow reserve in patients with hypercholesterolemia. Am J Cardiol 2004;93:1419-21. A10.PubMed
97.
Zurück zum Zitat Takagi A, Tsurumi Y, Ishizuka N, Omori H, Arai K, Hagiwara N, et al. Single administration of cerivastatin, an HMG-CoA reductase inhibitor, improves the coronary flow velocity reserve: A transthoracic Doppler echocardiography study. Heart Vessels 2006;21:298-301.PubMed Takagi A, Tsurumi Y, Ishizuka N, Omori H, Arai K, Hagiwara N, et al. Single administration of cerivastatin, an HMG-CoA reductase inhibitor, improves the coronary flow velocity reserve: A transthoracic Doppler echocardiography study. Heart Vessels 2006;21:298-301.PubMed
98.
Zurück zum Zitat Ilveskoski E, Lehtimäki T, Laaksonen R, Janatuinen T, Vesalainen R, Nuutila P, et al. Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype. Scand J Clin Lab Invest 2007;67:723-34.PubMed Ilveskoski E, Lehtimäki T, Laaksonen R, Janatuinen T, Vesalainen R, Nuutila P, et al. Improvement of myocardial blood flow by lipid-lowering therapy with pravastatin is modulated by apolipoprotein E genotype. Scand J Clin Lab Invest 2007;67:723-34.PubMed
99.
Zurück zum Zitat Akinboboye OO, Chou R-L, Bergmann SR. Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: A comparison of lisinopril and losartan. J Am Coll Cardiol 2002;40:703-9.PubMed Akinboboye OO, Chou R-L, Bergmann SR. Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: A comparison of lisinopril and losartan. J Am Coll Cardiol 2002;40:703-9.PubMed
100.
Zurück zum Zitat Masuda D, Nohara R, Tamaki N, Hosokawa R, Inada H, Hirai T, et al. Evaluation of coronary blood flow reserve by13 N-NH3 positron emission computed tomography (PET) with dipyridamole in the treatment of hypertension with the ACE inhibitor (Cilazapril). Ann Nucl Med 2000;14:353-60.PubMed Masuda D, Nohara R, Tamaki N, Hosokawa R, Inada H, Hirai T, et al. Evaluation of coronary blood flow reserve by13 N-NH3 positron emission computed tomography (PET) with dipyridamole in the treatment of hypertension with the ACE inhibitor (Cilazapril). Ann Nucl Med 2000;14:353-60.PubMed
101.
Zurück zum Zitat Chen J-W, Hsu N-W, Wu T-C, Lin S-J, Chang M-S. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 2002;90:974-82.PubMed Chen J-W, Hsu N-W, Wu T-C, Lin S-J, Chang M-S. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 2002;90:974-82.PubMed
102.
Zurück zum Zitat Kawata T, Daimon M, Hasegawa R, Teramoto K, Toyoda T, Sekine T, et al. Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: Comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist. Am Heart J 2006;151:798.e9-15. Kawata T, Daimon M, Hasegawa R, Teramoto K, Toyoda T, Sekine T, et al. Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: Comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist. Am Heart J 2006;151:798.e9-15.
103.
Zurück zum Zitat Kawata T, Daimon M, Hasegawa R, Teramoto K, Toyoda T, Sekine T, et al. Effect of angiotensin-converting enzyme inhibitor on serum asymmetric dimethylarginine and coronary circulation in patients with type 2 diabetes mellitus. Int J Cardiol 2009;132:286-8.PubMed Kawata T, Daimon M, Hasegawa R, Teramoto K, Toyoda T, Sekine T, et al. Effect of angiotensin-converting enzyme inhibitor on serum asymmetric dimethylarginine and coronary circulation in patients with type 2 diabetes mellitus. Int J Cardiol 2009;132:286-8.PubMed
104.
Zurück zum Zitat Hinoi T, Tomohiro Y, Kajiwara S, Matsuo S, Fujimoto Y, Yamamoto S, et al. Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy. Hypertens Res 2008;31:615-22.PubMed Hinoi T, Tomohiro Y, Kajiwara S, Matsuo S, Fujimoto Y, Yamamoto S, et al. Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy. Hypertens Res 2008;31:615-22.PubMed
105.
Zurück zum Zitat Pauly DF, Johnson BD, Anderson RD, Handberg EM, Smith KM, Cooper-DeHoff RM, et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation (WISE). Am Heart J 2011;162:678-84.PubMed Pauly DF, Johnson BD, Anderson RD, Handberg EM, Smith KM, Cooper-DeHoff RM, et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation (WISE). Am Heart J 2011;162:678-84.PubMed
106.
Zurück zum Zitat Schneider CA, Voth E, Moka D, Baer FM, Melin J, Bol A, et al. Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: A study using [15O] water dobutamine stress positron emission tomography. J Am Coll Cardiol 1999;34:1005-11.PubMed Schneider CA, Voth E, Moka D, Baer FM, Melin J, Bol A, et al. Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: A study using [15O] water dobutamine stress positron emission tomography. J Am Coll Cardiol 1999;34:1005-11.PubMed
107.
Zurück zum Zitat Motz W, Strauer BE. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension 1996;27:1031-8.PubMed Motz W, Strauer BE. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension 1996;27:1031-8.PubMed
108.
Zurück zum Zitat Kamezaki F, Tasaki H, Yamashita K, Shibata K, Hirakawa N, Tsutsui M, et al. Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: Comparison with calcium channel blocker. Hypertens Res 2007;30:699-706.PubMed Kamezaki F, Tasaki H, Yamashita K, Shibata K, Hirakawa N, Tsutsui M, et al. Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: Comparison with calcium channel blocker. Hypertens Res 2007;30:699-706.PubMed
109.
Zurück zum Zitat Xiaozhen H, Yun Z, Mei Z, Yu S. Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy. Blood Press 2010;19:40-7.PubMed Xiaozhen H, Yun Z, Mei Z, Yu S. Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy. Blood Press 2010;19:40-7.PubMed
110.
Zurück zum Zitat Böttcher M, Czernin J, Sun K, Phelps ME, Schelbert HR. Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. J Nucl Med 1997;38:442-6.PubMed Böttcher M, Czernin J, Sun K, Phelps ME, Schelbert HR. Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. J Nucl Med 1997;38:442-6.PubMed
111.
Zurück zum Zitat Billinger M, Seiler C, Fleisch M, Eberli FR, Meier B, Hess OM. Do beta-adrenergic blocking agents increase coronary flow reserve? J Am Coll Cardiol 2001;38:1866-71.PubMed Billinger M, Seiler C, Fleisch M, Eberli FR, Meier B, Hess OM. Do beta-adrenergic blocking agents increase coronary flow reserve? J Am Coll Cardiol 2001;38:1866-71.PubMed
112.
Zurück zum Zitat Gullu H, Erdogan D, Caliskan M, Tok D, Yildirim I, Sezgin AT, et al. Different effects of atenolol and nebivolol on coronary flow reserve. Heart 2006;92:1690-1.PubMed Gullu H, Erdogan D, Caliskan M, Tok D, Yildirim I, Sezgin AT, et al. Different effects of atenolol and nebivolol on coronary flow reserve. Heart 2006;92:1690-1.PubMed
113.
Zurück zum Zitat Erdogan D, Gullu H, Caliskan M, Ciftci O, Baycan S, Yildirir A, et al. Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy. Heart 2007;93:319-24.PubMed Erdogan D, Gullu H, Caliskan M, Ciftci O, Baycan S, Yildirir A, et al. Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy. Heart 2007;93:319-24.PubMed
114.
Zurück zum Zitat Neglia D, De Maria R, Masi S, Gallopin M, Pisani P, Pardini S, et al. Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy. Heart 2007;93:808-13.PubMed Neglia D, De Maria R, Masi S, Gallopin M, Pisani P, Pardini S, et al. Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy. Heart 2007;93:808-13.PubMed
115.
Zurück zum Zitat Togni M, Vigorito F, Windecker S, Abrecht L, Wenaweser P, Cook S, et al. Does the beta-blocker nebivolol increase coronary flow reserve? Cardiovasc Drugs Ther 2007;21:99-108.PubMed Togni M, Vigorito F, Windecker S, Abrecht L, Wenaweser P, Cook S, et al. Does the beta-blocker nebivolol increase coronary flow reserve? Cardiovasc Drugs Ther 2007;21:99-108.PubMed
116.
Zurück zum Zitat Galderisi M, D’Errico A, Sidiropulos M, Innelli P, de Divitiis O, de Simone G. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension. J Hypertens 2009;27:2108-15.PubMed Galderisi M, D’Errico A, Sidiropulos M, Innelli P, de Divitiis O, de Simone G. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension. J Hypertens 2009;27:2108-15.PubMed
117.
Zurück zum Zitat Zervos G, Zusman RM, Swindle LA, Alpert NM, Fischman AJ, Gewirtz H. Effects of nifedipine on myocardial blood flow and systolic function in humans with ischemic heart disease. Coron Artery Dis 1999;10:185-94.PubMed Zervos G, Zusman RM, Swindle LA, Alpert NM, Fischman AJ, Gewirtz H. Effects of nifedipine on myocardial blood flow and systolic function in humans with ischemic heart disease. Coron Artery Dis 1999;10:185-94.PubMed
118.
Zurück zum Zitat Yoshinaga K, Beanlands RSB, deKemp RA, Lortie M, Morin J, Aung M, et al. Effect of exercise training on myocardial blood flow in patients with stable coronary artery disease. Am Heart J 2006;151:1324.e11-8. Yoshinaga K, Beanlands RSB, deKemp RA, Lortie M, Morin J, Aung M, et al. Effect of exercise training on myocardial blood flow in patients with stable coronary artery disease. Am Heart J 2006;151:1324.e11-8.
119.
Zurück zum Zitat Coppola A, Marfella R, Coppola L, Tagliamonte E, Fontana D, Liguori E, et al. Effect of weight loss on coronary circulation and adiponectin levels in obese women. Int J Cardiol 2009;134:414-6.PubMed Coppola A, Marfella R, Coppola L, Tagliamonte E, Fontana D, Liguori E, et al. Effect of weight loss on coronary circulation and adiponectin levels in obese women. Int J Cardiol 2009;134:414-6.PubMed
120.
Zurück zum Zitat Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006;295:1556-65.PubMed Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006;295:1556-65.PubMed
121.
Zurück zum Zitat Gould KL, Ornish D, Scherwitz L, Brown S, Edens RP, Hess MJ, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA 1995;274:894-901.PubMed Gould KL, Ornish D, Scherwitz L, Brown S, Edens RP, Hess MJ, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA 1995;274:894-901.PubMed
122.
Zurück zum Zitat Venkataraman R, Belardinelli L, Blackburn B, Heo J, Iskandrian AE. A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images. JACC Cardiovasc Imaging 2009;2:1301-9.PubMed Venkataraman R, Belardinelli L, Blackburn B, Heo J, Iskandrian AE. A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images. JACC Cardiovasc Imaging 2009;2:1301-9.PubMed
123.
Zurück zum Zitat Venkataraman R, Aljaroudi W, Belardinelli L, Heo J, Iskandrian AE. The effect of ranolazine on the vasodilator-induced myocardial perfusion abnormality. J Nucl Cardiol 2011;18:456-62.PubMed Venkataraman R, Aljaroudi W, Belardinelli L, Heo J, Iskandrian AE. The effect of ranolazine on the vasodilator-induced myocardial perfusion abnormality. J Nucl Cardiol 2011;18:456-62.PubMed
124.
Zurück zum Zitat Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, van `t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-24.PubMed Tonino PAL, De Bruyne B, Pijls NHJ, Siebert U, Ikeno F, van `t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360:213-24.PubMed
125.
Zurück zum Zitat Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB III, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:e166-286.PubMed Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB III, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:e166-286.PubMed
Metadaten
Titel
Non-invasive quantification of coronary vascular dysfunction for diagnosis and management of coronary artery disease
verfasst von
Venkatesh L. Murthy, MD, PhD
Marcelo F. Di Carli, MD
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 5/2012
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-012-9590-1

Weitere Artikel der Ausgabe 5/2012

Journal of Nuclear Cardiology 5/2012 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.